News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
ASX Large Caps: Shares flat after strong jobs data and updates from miners; Telix tumbles 15pc on Q2 results
Tech
These tech and pharma stocks are looking to M&A to drive growth in global markets
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Health & Biotech
These were the best ASX biotechs as Health Care sprang back to life in FY23
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: ASX health stocks up as Avita Medical gets US FDA green light
News
ASX Large Caps: Energy stocks slump, but Telstra, Woolworths, QBE touch 12-month highs
Health & Biotech
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines
Health & Biotech
4D Medical’s technology disrupts century-old procedures AND makes over 90pc profit margin
News
ASX Large Caps: Shares jump after guidance upgrades by Origin, Judo and Transurban
Health & Biotech
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales
Health & Biotech
ScoPo’s (actually still Iain’s) Powerplays: ASX health sector falls, but several stocks on upward run
Health & Biotech
ScoPo’s (actually Iain’s) Powerplays: ASX health stocks fall, Neuren’s DAYBUE drug officially rolling out in US
News
ASX Large Caps: Shares slump on RBA minutes, BlackRock ditches its 60-40 investment strategy
News
ASX Large Caps: Aussie inflation finally eases; SBF charged with bribing Chinese officials
Health & Biotech
Why growth is a positive for the ASX medical imaging sector
News
After Neuren’s success, which other ASX health stocks are knocking on the US FDA door?
Health & Biotech